Iris Grossman

Company: Eleven Therapeutics

Job title: Chief Therapeutics Officer

Seminars:

Expert Panel Discussion: The Right Delivery for the Right Therapeutic Area 9:30 am

The major challenge to harnessing RNAi for the treatment of disease is delivery of functional nucleic acid to the target tissues, cells, and subcellular compartments. This panel will discuss challenges and solutions they have found in their specific areas of interest.Read more

day: Conference Day Two

DELiveri™: A Conjugate Discovery Platform, Empowered by Combinatorial Chemistry & AI, for ex-Hepatic Selective Delivery of Synthetic RNA 12:00 pm

• The DELiveri™ platform ushers in a new era of precision in nucleic acid medicine, enabling high-throughput screening (HTS) of cell-specific targeting small molecules • DELiveri™ uses a proprietary engineered genetic circuit that transforms screened cells into MOLECULAR RADARs • Once coupled with DNA-encoded libraries (DELs) and AI for analysis, HTS outputs generate quantitative signals…Read more

day: Conference Day One